Last updated on April 2019

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure


Brief description of study

Sleep Apnea (SA) is a disorder that causes pauses in breathing during sleep that expose the heart to oxygen deprivation. It is common in patients with heart failure (HF) where it is associated with increased risk of hospitalizations and death. It is not known however whether treating SA reduces these risks. This study is looking at whether a respiratory device known as Adaptive Servo Ventilation (ASV) can reduce the rate of cardiovascular hospitalizations and death in subjects with HF and SA. Study subjects will randomly receive either their regular medications OR their regular medications plus ASV. They will be followed for approximately 5 years and information relevant to their health will be collected and compared.

Clinical Study Identifier: NCT01128816

Find a site near you

Start Over

MetroHealth Medical Centre

Cleveland, OH United States
  Connect »

Ohio State University

Columbus, OH United States
  Connect »